Clearmind Medicine Statistics
Total Valuation
CMND has a market cap or net worth of $5.49 million. The enterprise value is -$375,701.
Important Dates
The last earnings date was Thursday, March 13, 2025, after market close.
Earnings Date | Mar 13, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
CMND has 5.13 million shares outstanding. The number of shares has increased by 582.94% in one year.
Current Share Class | 5.13M |
Shares Outstanding | 5.13M |
Shares Change (YoY) | +582.94% |
Shares Change (QoQ) | +10.00% |
Owned by Insiders (%) | 2.50% |
Owned by Institutions (%) | 5.26% |
Float | 4.66M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 1.76 |
P/TBV Ratio | 2.00 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.72, with a Debt / Equity ratio of 0.02.
Current Ratio | 1.72 |
Quick Ratio | 1.64 |
Debt / Equity | 0.02 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -139.62 |
Financial Efficiency
Return on equity (ROE) is -125.61% and return on invested capital (ROIC) is -91.12%.
Return on Equity (ROE) | -125.61% |
Return on Assets (ROA) | -43.89% |
Return on Invested Capital (ROIC) | -91.12% |
Return on Capital Employed (ROCE) | -204.75% |
Revenue Per Employee | n/a |
Profits Per Employee | -$1.24M |
Employee Count | 4 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
In the past 12 months, CMND has paid $215,801 in taxes.
Income Tax | 215,801 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -8.55% in the last 52 weeks. The beta is -1.46, so CMND's price volatility has been lower than the market average.
Beta (5Y) | -1.46 |
52-Week Price Change | -8.55% |
50-Day Moving Average | 1.27 |
200-Day Moving Average | 1.37 |
Relative Strength Index (RSI) | 38.09 |
Average Volume (20 Days) | 59,365 |
Short Selling Information
The latest short interest is 194,509, so 3.79% of the outstanding shares have been sold short.
Short Interest | 194,509 |
Short Previous Month | 255,617 |
Short % of Shares Out | 3.79% |
Short % of Float | 4.17% |
Short Ratio (days to cover) | 3.70 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -5.86M |
Pretax Income | -6.68M |
Net Income | -4.96M |
EBITDA | -5.85M |
EBIT | -5.86M |
Earnings Per Share (EPS) | -$1.29 |
Full Income Statement Balance Sheet
The company has $5.92 million in cash and $45,997 in debt, giving a net cash position of $5.87 million or $1.14 per share.
Cash & Cash Equivalents | 5.92M |
Total Debt | 45,997 |
Net Cash | 5.87M |
Net Cash Per Share | $1.14 |
Equity (Book Value) | 2.85M |
Book Value Per Share | 0.61 |
Working Capital | 2.69M |
Full Balance Sheet Cash Flow
Operating Cash Flow | -4.66M |
Capital Expenditures | n/a |
Free Cash Flow | -4.66M |
FCF Per Share | -$0.91 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |